Found: 21
Select item for more details and to access through your institution.
Editorial Board.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. A1, doi. 10.1016/S1525-7304(21)00298-9
- Publication type:
- Article
A Reasonable Definition of Oligo-Recurrence in Non–Small-Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 82, doi. 10.1016/j.cllc.2021.10.013
- By:
- Publication type:
- Article
Acquired MET-DSTN Fusion Mediated Resistance to EGFR-TKIs in Lung Adenocarcinoma and Responded to Crizotinib Plus Gefitinib: A Case Report.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e83, doi. 10.1016/j.cllc.2021.10.006
- By:
- Publication type:
- Article
Overall Treatment Strategy for Patients With Metastatic NSCLC With Activating EGFR Mutations.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e69, doi. 10.1016/j.cllc.2021.10.009
- By:
- Publication type:
- Article
Results of Second Round Lung Cancer Screening by Low-Dose CT scan - French Cohort Study (DEP-KP80).
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e54, doi. 10.1016/j.cllc.2021.09.009
- By:
- Publication type:
- Article
Table of Contents.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. A2, doi. 10.1016/S1525-7304(21)00299-0
- Publication type:
- Article
The Combiome Hypothesis: Selecting Optimal Treatment for Cancer Patients.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 1, doi. 10.1016/j.cllc.2021.08.011
- By:
- Publication type:
- Article
Frequent EGFR Mutations and Better Prognosis in Positron Emission Tomography-Negative, Solid-Type Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e60, doi. 10.1016/j.cllc.2021.10.003
- By:
- Publication type:
- Article
Treatment Patterns and Outcomes of Patients With Advanced Pleural Mesothelioma at an Academic Referral Centre.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e43, doi. 10.1016/j.cllc.2021.08.003
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio is correlated to driver gene mutations in surgically-resected non-small cell lung cancer and its post-operative evolution impacts outcomes.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e29, doi. 10.1016/j.cllc.2021.08.001
- By:
- Publication type:
- Article
EGFR High Copy Number Together With High EGFR Protein Expression Predicts Improved Outcome for Cetuximab-based Therapy in Squamous Cell Lung Cancer: Analysis From SWOG S0819, a Phase III Trial of Chemotherapy With or Without Cetuximab in Advanced NSCLC.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 60, doi. 10.1016/j.cllc.2021.10.002
- By:
- Publication type:
- Article
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non–Small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 72, doi. 10.1016/j.cllc.2021.10.001
- By:
- Publication type:
- Article
PD-L1 Expression and Comprehensive Molecular Profiling Predict Survival in Nonsmall Cell Lung Cancer: A Real-World Study of a Large Chinese Cohort.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 43, doi. 10.1016/j.cllc.2021.08.009
- By:
- Publication type:
- Article
The Effects of HER2 Alterations in EGFR Mutant Non-small Cell Lung Cancer.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 52, doi. 10.1016/j.cllc.2021.08.012
- By:
- Publication type:
- Article
Current Strategies for Extensive Stage Small Cell Lung Cancer Beyond First-line Therapy.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 14, doi. 10.1016/j.cllc.2021.09.003
- By:
- Publication type:
- Article
Immune-Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer With Uncommon Histology.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e17, doi. 10.1016/j.cllc.2021.06.013
- By:
- Publication type:
- Article
Central Nervous System Response to Selpercartinib in Patient With RET-rearranged Non-small Cell Lung Cancer After Developing Leptomeningeal Disease on Pralsetinib.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e5, doi. 10.1016/j.cllc.2021.06.005
- By:
- Publication type:
- Article
Real-World Incidence of Pneumonitis in Patients Receiving Durvalumab.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 34, doi. 10.1016/j.cllc.2021.08.006
- By:
- Publication type:
- Article
Clinical Behavior of Combined Versus Pure High-Grade Neuroendocrine Carcinoma.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e9, doi. 10.1016/j.cllc.2021.06.010
- By:
- Publication type:
- Article
The Common Thread: A Case of Synchronous Lung Cancers and a Germline CHEK2 Mutation.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. e1, doi. 10.1016/j.cllc.2021.05.011
- By:
- Publication type:
- Article
Comparison of SP142 and 22C3 Immunohistochemistry PD-L1 Assays for Clinical Efficacy of Atezolizumab in Non–Small Cell Lung Cancer: Results From the Randomized OAK Trial.
- Published in:
- Clinical Lung Cancer, 2022, v. 23, n. 1, p. 21, doi. 10.1016/j.cllc.2021.05.007
- By:
- Publication type:
- Article